Zobrazeno 1 - 10
of 28
pro vyhledávání: '"JF Legrand"'
Publikováno v:
Section 3: Production and compounding.
Autor:
C. Faes, JF Legrand, B. Dekyndt, Franck Semah, E. Marchal, M.A. Hubaut, A. Dubois, K. Sadoune, H. Lahousse, F. Hives
Publikováno v:
Médecine Nucléaire. 45:233
Introduction La microlithiase alveolaire pulmonaire (MAP) est une pathologie infiltrante pulmonaire, rare, caracterisee par la presence de cristaux d’hydroxyapatite dans l’espace alveolaire. Decrite initialement par Malpighi en 1686, moins de 150
Publikováno v:
Other hospital pharmacy topics.
Background Radiolabelled leukocytes are one of the most specific scintigraphy examinations to diagnose deep tissue infection. White blood cells are isolated by sedimentation and centrifugation and then labelled with radioactive drugs. A few checks ar
Publikováno v:
Other hospital pharmacy topics.
Background In nuclear medicine, [18F]-fluorodeoxyglucose (18-FDG) is usually administered in unit doses partitioned from multi-dose vials in radiopharmacy. Administration can be performed manually or automatically. In a nuclear medicine department wh
Publikováno v:
Physical Review E. 52:738-745
We have measured coherent neutron scattering from deuterated orthoterphenyl on a spin echo and a backscattering spectrometer. In agreement with mode coupling theory, pair correlations decay in two steps and follow the same scaling laws as those found
Autor:
Stephen Doyle, Lucia Hartmann, Peter Reiss, Frédéric Chandezon, Lucian Roiban, Martin Brinkmann, Angela Fiore, Jf Legrand, David Djurado, Ovidiu Ersen
Publikováno v:
Nanoscale, 4(22), 7212-7220. Royal Society of Chemistry
Nanoscale
Nanoscale, Royal Society of Chemistry, 2012, 4 (22), pp.7212
Nanoscale, 2012, 4 (22), pp.7212. ⟨10.1039/c2nr32071a⟩
Nanoscale
Nanoscale, Royal Society of Chemistry, 2012, 4 (22), pp.7212
Nanoscale, 2012, 4 (22), pp.7212. ⟨10.1039/c2nr32071a⟩
Highly oriented and nanostructured hybrid thin films made of regioregular poly(3-hexylthiophene) and colloidal CdSe nanocrystals are prepared by a zone melting method using epitaxial growth on 1,3,5-trichlorobenzene oriented crystals. The structure o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfec7f930ce1d2b2f8eb10e33ab726d0
https://pure.amc.nl/en/publications/mapping-the-3d-distribution-of-cdse-nanocrystals-in-highly-oriented-and-nanostructured-hybrid-p3htcdse-films-grown-by-directional-epitaxial-crystallization(2d626fe5-c74b-4065-b245-ed160c0e72a1).html
https://pure.amc.nl/en/publications/mapping-the-3d-distribution-of-cdse-nanocrystals-in-highly-oriented-and-nanostructured-hybrid-p3htcdse-films-grown-by-directional-epitaxial-crystallization(2d626fe5-c74b-4065-b245-ed160c0e72a1).html
Autor:
Pascal Odou, Nicolas Simon, M Pinturaud, M Lebecque, M Vasseur, Bertrand Décaudin, JF Legrand, Christine Barthélémy
Publikováno v:
European Journal of Hospital Pharmacy. 22:A193.1-A193
Background For several years, many infusion systems have been marketed for the administration of antineoplastic drugs (AD). Purpose To compare the ability of these devices to deliver the expected volume of antineoplastic drug in solution. Material an
Autor:
Durieux F; Institute of Pharmacy, CHU Lille, F-59000 Lille, France.; Nuclear Medicine Department, CHU Lille, F-59000 Lille, France., Dekyndt B; Institute of Pharmacy, CHU Lille, F-59000 Lille, France.; Nuclear Medicine Department, CHU Lille, F-59000 Lille, France.; EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France., Legrand JF; Institute of Pharmacy, CHU Lille, F-59000 Lille, France.; Nuclear Medicine Department, CHU Lille, F-59000 Lille, France., Rogeau A; Nuclear Medicine Department, CHU Lille, F-59000 Lille, France., Malek E; Radiopharmacy Unit-Institute of Pharmacy, CH Valenciennes, F-59300 Valenciennes, France., Semah F; Nuclear Medicine Department, CHU Lille, F-59000 Lille, France.; Inserm U1171, University of Lille, F-59000 Lille, France., Odou P; Institute of Pharmacy, CHU Lille, F-59000 Lille, France.; EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Nov 01; Vol. 16 (11). Date of Electronic Publication: 2023 Nov 01.
Autor:
Vermandel M; Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France maximilien.vermandel@univ-lille.fr.; Medical Physics Department, CHU de Lille, Lille, France.; Neurosurgery Department, Hospital Salengro, CHU de Lille, Lille, France.; Onco-ThAI, INSERM U1189, Université de Lille, CHU de Lille, Lille, France., Debruyne P; Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France., Beron A; Nuclear Medicine Department, Hospital Huriez, CHU de Lille, Lille, France; and., Devos L; Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France.; Medical Physics Department, CHU de Lille, Lille, France., Talbot A; Medical Physics Department, CHU de Lille, Lille, France.; Neurosurgery Department, Hospital Salengro, CHU de Lille, Lille, France., Legrand JF; Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France., Provôt F; Nephrology Department, Hospital Huriez, CHU de Lille, Lille, France., Lion G; Nuclear Medicine Department, Hospital Salengro, CHU de Lille, Lille, France.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2020 Aug; Vol. 61 (8), pp. 1161-1170. Date of Electronic Publication: 2020 Jan 10.
Autor:
Simon N; Institut de Pharmacie, CHRU; †Univ Lille, F-59000; and ‡UDSL, EA 7365 GRITA, F-59000, Lille, France., Vasseur M, Guillaussier A, Legrand JF, Lebecque M, Barthélémy C, Décaudin B, Odou P
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2016 Apr; Vol. 38 (2), pp. 268-73.